Close Menu

Note: The story mistakenly said that Sentinel's clinical chemistry assays run on instruments from Thermo Fisher. The error has been corrected.

NEW YORK – With two new SARS-CoV-2 diagnostic kits hitting the market, Milan-based Sentinel Diagnostics is looking to expand into the US market and continue its partnerships with major US companies. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.